MediWound Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, dated June 22, 2017, reports on the Annual General Meeting of Shareholders held by MediWound Ltd. on that date. The filing serves to disclose the voting results of seven proposals presented to shareholders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a corporate governance report regarding shareholder voting and does not contain financial performance data.
Material Changes
No material financial changes are reported in this filing. The primary event is the successful approval of seven shareholder proposals. As of the Record Date (May 22, 2017), there were 21,954,078 ordinary shares issued and outstanding. At the meeting, 14,113,840 shares were present in person or by proxy, representing 64.3% of outstanding shares, satisfying the quorum requirement.
Guidance, Outlook, and Risks
The filing does not contain management guidance, future outlook, risk factors, or contingencies. It confirms that all seven proposals were approved based on the majority requirements under the Israeli Companies Law and the Company's Articles of Association.
Key Facts for Investors to Verify
- All seven shareholder proposals were approved at the June 22, 2017 meeting.
- Shareholder attendance represented 64.3% of outstanding shares.
- Details of the specific proposals are located in the proxy statement filed on May 17, 2017 (Exhibit 99.1).
- This filing contains no financial performance metrics; investors should refer to Form 20-F for financial data.